MHC-I is delivered to the cell surface by the Golgi apparatus to present tumor-associated peptides to CD8+ T cells, and CD8+ T cells recognize antigenic peptide fragments through the TCR as peptide-MHC-I complexes on transformed cells. Here, CD8A is linked to neoplasm.